HealthEquity Inc. (HQY)

62.18
NASDAQ : Finance
Prev Close 64.69
Day Low/High 61.68 / 66.49
52 Wk Low/High 50.29 / 101.58
Avg Volume 860.10K
Exchange NASDAQ
Shares Outstanding 62.73M
Market Cap 4.06B
EPS 1.20
P/E Ratio 44.31
Div & Yield N.A. (N.A)

Latest News

Starbucks, DexCom, HealthEquity: 'Mad Money' Lightning Round

Starbucks, DexCom, HealthEquity: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Starbucks, DexCom, HealthEquity, Turning Point Brands, Tilray, CVS Health, Timken and more.

What Are Mergers and Acquisitions? Definitions and What You Need to Know

What Are Mergers and Acquisitions? Definitions and What You Need to Know

Mergers and acquisitions are a huge part of business activity and transactions - and have created some of the biggest conglomerates in the world. So, what are they, and what do they do?

WageWorks Jumps After Receiving Unsolicited Bid From HealthEquity

WageWorks Jumps After Receiving Unsolicited Bid From HealthEquity

WageWorks says it will 'carefully review the proposal.'

HealthEquity Confirms Proposal To Acquire WageWorks For $50.50 Per Share In Cash

HealthEquity Confirms Proposal To Acquire WageWorks For $50.50 Per Share In Cash

HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation's largest independent health savings account ("HSA") custodian, today confirmed that it has made a proposal to acquire all of the outstanding shares of WageWorks, Inc.

Markets Get a Lyft: Cramer's 'Mad Money' Recap (Friday 3/29/19)

Markets Get a Lyft: Cramer's 'Mad Money' Recap (Friday 3/29/19)

The biggest IPO of the year so far is likely to set a trend, Jim Cramer says.

Bargains Are Being Created: Cramer's 'Mad Money' Recap (Friday 12/14/18)

Bargains Are Being Created: Cramer's 'Mad Money' Recap (Friday 12/14/18)

It's a brutal market these days, but bargains are being created, Jim Cramer told Mad Money viewers Friday.

Children's Place, Synchrony, Yeti and more: 'Mad Money' Lightning Round

Children's Place, Synchrony, Yeti and more: 'Mad Money' Lightning Round

Jim Cramer weighs in on Children's Place, Synchrony, Yeti and more.

You Need a Game Plan: Cramer's 'Mad Money' Recap (Friday 10/19/18)

You Need a Game Plan: Cramer's 'Mad Money' Recap (Friday 10/19/18)

Jim Cramer is ready to call the Fed out. And he has your game plan ready for next week.

GoPro, Eli Lilly, HealthEquity: 'Mad Money' Lightning Round

GoPro, Eli Lilly, HealthEquity: 'Mad Money' Lightning Round

Jim Cramer weighs in on GoPro, Eli Lilly, HealthEquity, General Mills, and Marriott International.

Good Job Growth, Low Inflation: Cramer's 'Mad Money' Recap (Friday 6/1/18)

Good Job Growth, Low Inflation: Cramer's 'Mad Money' Recap (Friday 6/1/18)

Jim Cramer says the market like this economy; he has your game plan for next week.

HealthEquity Sets Date To Announce Year-end Results

HealthEquity Sets Date To Announce Year-end Results

Attend Investor Conference

HQY Crosses Above Average Analyst Target

HQY Crosses Above Average Analyst Target

In recent trading, shares of HealthEquity Inc have crossed above the average analyst 12-month target price of $57.10, changing hands for $57.58/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

HealthEquity Reports Year-End Sales Metrics

HealthEquity Reports Year-End Sales Metrics

Custodial Assets of $6.8 billion, up 35% year-over-year, HSA Members up 24%

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AWI, BIDU, CLF, EQR, ESCA, FTAI, GPX, HBIO, HQY, JW.B, NLSN, SF, SYF, TBI, TCRD, VSEC, WTS Downgrades: DFT, EDR, HTA, HURN, LNDC, MLAB, NC, ORC Initiations: HONE Read on to get TheStreet Quant Ratings' detailed report:

TheStreet Quant Rating: B (Buy)